Login / Signup

Selective molecular impairment of spontaneous neurotransmission modulates synaptic efficacy.

Devon C CrawfordDenise M O RamirezBrent TrautermanLisa M MonteggiaEge T Kavalali
Published in: Nature communications (2017)
Recent studies suggest that stimulus-evoked and spontaneous neurotransmitter release processes are mechanistically distinct. Here we targeted the non-canonical synaptic vesicle SNAREs Vps10p-tail-interactor-1a (vti1a) and vesicle-associated membrane protein 7 (VAMP7) to specifically inhibit spontaneous release events and probe whether these events signal independently of evoked release to the postsynaptic neuron. We found that loss of vti1a and VAMP7 impairs spontaneous high-frequency glutamate release and augments unitary event amplitudes by reducing postsynaptic eukaryotic elongation factor 2 kinase (eEF2K) activity subsequent to the reduction in N-methyl-D-aspartate receptor (NMDAR) activity. Presynaptic, but not postsynaptic, loss of vti1a and VAMP7 occludes NMDAR antagonist-induced synaptic potentiation in an intact circuit, confirming the role of these vesicular SNAREs in setting synaptic strength. Collectively, these results demonstrate that spontaneous neurotransmission signals independently of stimulus-evoked release and highlight its role as a key regulator of postsynaptic efficacy.
Keyphrases
  • high frequency
  • prefrontal cortex
  • transcranial magnetic stimulation
  • transcription factor
  • drug delivery
  • cancer therapy
  • drug induced
  • living cells
  • fluorescent probe